Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIVE-AIR: Lenzilumab in Hospitalized COVID-19 Pneumonia
NCT04351152Phase 3Unknown
- Sponsor
- Humanigen
- Start
- May 2020
- Primary completion
- Mar 2021
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of lenzilumab in COVID-19 pneumonia, sponsored by Humanigen. Status: unknown.
02
Drugs
lenzilumab
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04351152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04351152.